Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Leggi l'articolo originale


Journal of Clinical Oncology, Ahead of Print.

Lascia un commento